Wu Qiao-Feng, Zhu Wen-Rui, Yan Yun-Liang, Zhang Xiao-Xia, Jiang Ya-Qi, Zhang Feng-Ling
Zhejiang Chinese Medical University, Hangzhou 310053, China.
J Ethnopharmacol. 2016 Jun 5;185:282-8. doi: 10.1016/j.jep.2016.02.042. Epub 2016 Mar 3.
Huangliang Xiangru Decoction (HXD), which is described in a famous TCM monograph "Book of Nanyang for Life Savin", is frequently used for treating cold in summer and summer heat-dampness.
To date, no pharmacological study on the anti-H1N1 influenza properties of HXD has been reported. The aim of the present study was to evaluate the therapeutic action of HXD on HIN1-induced acute pulmonary inflammation and its anti-influenza mechanism focus to TLRs signal pathway in a mouse model.
the mice were intranasally infected with influenza virus to induce viral pneumonia, and then treated with different doses of HXD. The Lung index and pathological changes in the lung tissue of mice were investigated to value the anti-influenza virus effect of HXD. The concentrations of cytokines (IL-2, IL-6, TNF-α and IFN-γ) and anti-oxidant factor (NO, SOD and GSH) in serum of mice were determined with ELISA. RT-PCR and Western blot were used to determine the mRNA and protein expression of TLR3, TLR7, MyD88,TRAF3 and NF-κB p65 in the lung tissues, which are the key targets of TLRs pathway.
Compared with the infection group, the lung index of mice in ribavirin group, HXD high dose group and HXD middle dose group were significantly decreased, the lung indexes of these groups were 10.36±1.14mg/g, 9.89±0.79mg/g, and 10.97±0.67mg/g. Moreover, pathological changes were remarkable alleviated. HXD can reduce the contents of IL-6, TNF-α and IFN-γ, NO, and increase the contents of IL-2, SOD, GSH in serum of infected-mice significantly. At the same time, HXD can reduce the mRNA and protein expression of TLR3, TLR7, MyD88,TRAF3 and NF-κB p65 in the lung tissues of infected-mice significantly.
HXD has significant effects on H1N1 influenza by a quantity-effect relationship, and plays its anti-influenza effect by enhancing the body's antioxidant capacity, regulating the body's immune function and the host's TLRs pathway.
《南阳活人书》这本著名的中医专著中记载的黄粱香薷汤(HXD),常用于治疗夏季感冒和暑湿。
迄今为止,尚未有关于HXD抗H1N1流感特性的药理学研究报道。本研究的目的是在小鼠模型中评估HXD对HIN1诱导的急性肺部炎症的治疗作用及其针对TLRs信号通路的抗流感机制。
通过鼻腔感染流感病毒诱导小鼠发生病毒性肺炎,然后用不同剂量的HXD进行治疗。研究小鼠肺指数及肺组织病理变化,以评估HXD的抗流感病毒效果。采用酶联免疫吸附测定法(ELISA)测定小鼠血清中细胞因子(白细胞介素-2、白细胞介素-6、肿瘤坏死因子-α和干扰素-γ)和抗氧化因子(一氧化氮、超氧化物歧化酶和谷胱甘肽)的浓度。采用逆转录聚合酶链反应(RT-PCR)和蛋白质免疫印迹法(Western blot)测定肺组织中TLR3、TLR7、髓样分化因子88(MyD88)、肿瘤坏死因子受体相关因子3(TRAF3)和核因子κB p65的mRNA和蛋白表达,这些是TLRs通路的关键靶点。
与感染组相比,利巴韦林组、HXD高剂量组和HXD中剂量组小鼠的肺指数显著降低,这些组的肺指数分别为10.36±1.14mg/g、9.89±0.79mg/g和10.97±0.67mg/g。此外,病理变化明显减轻。HXD可显著降低感染小鼠血清中白细胞介素-6、肿瘤坏死因子-α、干扰素-γ和一氧化氮的含量,并增加白细胞介素-2、超氧化物歧化酶和谷胱甘肽的含量。同时,HXD可显著降低感染小鼠肺组织中TLR3、TLR7、MyD88、TRAF3和核因子κB p65的mRNA和蛋白表达。
HXD对H1N1流感具有显著的量效关系,通过增强机体抗氧化能力、调节机体免疫功能和宿主TLRs通路发挥抗流感作用。